These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8925581)

  • 21. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
    Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
    Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of digitalis on left ventricular functional response to exercise in congestive heart failure.
    Morisco C; Cuocolo A; Romano M; Nappi A; Iaccarino G; Volpe M; Salvatore M; Trimarco B
    Am J Cardiol; 1996 Mar; 77(7):480-5. PubMed ID: 8629588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure.
    Macdonald PS; Keogh AM; Aboyoun C; Lund M; Amor R; McCaffrey D
    Heart; 1999 Nov; 82(5):589-93. PubMed ID: 10525515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac and hemodynamic effects of intravenous dofetilide in patients with heart failure.
    Rousseau MF; Massart PE; van Eyll C; Etienne J; Ahn S; Ghadanfar M; Friedrich T; Pouleur H
    Am J Cardiol; 2001 Jun; 87(11):1250-4. PubMed ID: 11377349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Randomized Placebo-Controlled Trial.
    McMurray JJV; Ponikowski P; Bolli GB; Lukashevich V; Kozlovski P; Kothny W; Lewsey JD; Krum H;
    JACC Heart Fail; 2018 Jan; 6(1):8-17. PubMed ID: 29032139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with carvedilol and amiodarone in patients with severe heart failure.
    Nägele H; Bohlmann M; Eck U; Petersen B; Rödiger W
    Eur J Heart Fail; 2000 Mar; 2(1):71-9. PubMed ID: 10742706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose amiodarone in severe chronic heart failure.
    Biswas A; Dey SK; Banerjee AK; Roy S; Biswas PK; Chowdhury GK; Khan AK; Mitra KK; Chatterjee SS; Maity AK
    Indian Heart J; 1996; 48(4):361-4. PubMed ID: 8908821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
    Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
    Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.
    Di Biase L; Mohanty P; Mohanty S; Santangeli P; Trivedi C; Lakkireddy D; Reddy M; Jais P; Themistoclakis S; Dello Russo A; Casella M; Pelargonio G; Narducci ML; Schweikert R; Neuzil P; Sanchez J; Horton R; Beheiry S; Hongo R; Hao S; Rossillo A; Forleo G; Tondo C; Burkhardt JD; Haissaguerre M; Natale A
    Circulation; 2016 Apr; 133(17):1637-44. PubMed ID: 27029350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
    Udelson JE; McGrew FA; Flores E; Ibrahim H; Katz S; Koshkarian G; O'Brien T; Kronenberg MW; Zimmer C; Orlandi C; Konstam MA
    J Am Coll Cardiol; 2007 Jun; 49(22):2151-9. PubMed ID: 17543634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Freudenberger RS; Hellkamp AS; Halperin JL; Poole J; Anderson J; Johnson G; Mark DB; Lee KL; Bardy GH;
    Circulation; 2007 May; 115(20):2637-41. PubMed ID: 17485579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of congestive heart failure and alterations in left ventricular function in patients with sustained ventricular tachyarrhythmias treated with amiodarone.
    De Paola AA; Horowitz LN; Spielman SR; Brady P; Morganroth J; Greenspan AM; Kay HR
    Am J Cardiol; 1987 Aug; 60(4):276-80. PubMed ID: 3303888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Veterans Affairs congestive heart failure antiarrhythmic trial. CHF STAT Investigators.
    Singh SN; Fletcher RD; Fisher S; Lazzeri D; Deedwania P; Lewis D; Massie B; Singh BN; Colling C
    Am J Cardiol; 1993 Nov; 72(16):99F-102F. PubMed ID: 8237838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
    Cairns JA; Connolly SJ; Roberts R; Gent M
    Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
    Komajda M; Isnard R; Cohen-Solal A; Metra M; Pieske B; Ponikowski P; Voors AA; Dominjon F; Henon-Goburdhun C; Pannaux M; Böhm M;
    Eur J Heart Fail; 2017 Nov; 19(11):1495-1503. PubMed ID: 28462519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study.
    Navarro-Peñalver M; Perez-Martinez MT; Gómez-Bueno M; García-Pavía P; Lupón-Rosés J; Roig-Minguell E; Comin-Colet J; Bayes-Genis A; Noguera JA; Pascual-Figal DA
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):543-550. PubMed ID: 29929385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.